First COVID nasal vaccine by Bharat Biotech gets regulator’s nod for holding phase 2, 3 clinical trials Nation First COVID nasal vaccine by Bharat Biotech gets regulator’s nod for holding phase 2, 3 clinical trials News Analysis India 3 years ago By PTI NEW DELHI: The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator’s nod for conducting phase 2 and 3...Read More